Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Pfizer 3Q | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Pfizer 3Q

Total pharmaceutical sales in the quarter were $10.7 billion (-3%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pfizer 3Q

3Q Revenues: $11.6 billion (-3%)

3Q Earnings: $2.9 billion (+26%)

YTD Revenues: $33.5 billion (-7%)

YTD Earnings: $7.9 billion (flat)

Comments: Total pharmaceutical sales in the quarter were $10.7 billion (-3%). Primary Care sales were down 4% to $5.5 billion. Specialty Care sales were up 3% to $1.6 billion. Oncology revenue was $371 million (-5%). Established Products revenue was $1.6 billion (-12%) and Emerging Markets revenue was $1.6 billion (-4%). U.S. revenues were $4.8 billion (-2%) in the quarter and international revenues were $6.8 billion (-4%). YTD U.S. revenues were $14.3 billion (-6%) and international revenues were $19.2 billion (-8%). Revenues in the quarter and YTD were unfavorably impacted by 5% and 6% respectively, due to foreign exchange. R&D expenses were down 13% to $1.6 billion in the quarter and down 11% to 5.0 billion YTD.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters